Abstract

Mucormycosis is an opportunistic fungal infection that typically affects immunocompromised patients, particularly patients with uncontrolled diabetes mellitus. India has reported a surge in cases of post covid 19 mucormycosis patients due to the increasing frequency of risk factors in the patients. To study the correlation of inflammatory markers and covid antibody titre in mucormycosis mucormycosis patients. Materials and Method: The work was conducted in L.L.R.M MEDICAL COLLEGE and associated SVBP HOSPITAL, MEERUT. All the mucormycosis Patients attending medicine OPD/ IPD/ COVID HOSPITAL/ EMERGENCY WARD/ MUCORMYCOSIS WARD were included. Results: A maximum (32.3%) of cases were in the age group of 41-50 while the least (5.3%) were less than 30 years of age.most of the study participants were male (61.3%) and the majority of the patients (90.3%) were diabetic. On analysis, inflammatory markers level was found to be elevated in those participants who received oxygen therapy during study period.; whereas covid antibody titre doesn’t seems to be correlate with inflammatory markers level. Conclusion: There has been an upsurge of mucormycosis cases in India in the second wave of COVID-19. A major portion of cases has been of rhino-orbit-cerebral mucormycosis affecting those who have co-existent COVID-19 or have recently recovered from COVID-19

Description

.